FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| MK-0773, 606101-58-0, MK-0773 Intermediate 86283-81-0, stock 593.2g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| MK-0773, 606101-58-0, MK-0773 Intermediate 606101-77-3, stock 892.9g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
| MK-0773, 606101-58-0, MK-0773 Intermediate 606101-78-4, stock 584.1g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| MK-0773, 606101-58-0, MK-0773 Intermediate 606101-79-5, stock 469g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| MK-0773, 606101-58-0, MK-0773 Intermediate 828242-03-1, stock 968.8g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| MK-0773, 606101-58-0, MK-0773 Intermediate 606101-58-0, stock 965.5g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
